Bionano Genomics announces presentation of OGM utility at ISSCR meeting

Bionano Genomics announced its participation in the International Society for Stem Cell Research Annual Meeting 2023 with a broad range of content covering the utility of optical genome mapping for research, development, and manufacturing applications in stem cell therapy. ISSCR’s annual meeting brings together industry, medical, and academic professionals to discuss advances in stem cell research and regenerative medicine. The ISSCR conference will be held June 14-17, 2023, online and in-person in Boston, Massachusetts. As part of a sponsored session titled “Optical Genome Mapping – Redefining Cell Line Genomic Integrity and Off-target Characterization,” three experts will share their experiences using OGM in their research, development and manufacturing processes. Presentations will cover OGM’s utility for monitoring genomic integrity and off-target effects in cell lines and its potential to improve the quality, safety, and overall risk profile of next-generation therapy development and manufacturing. Dr. Alex Hastie, Dr. Suk See De Ravin from National Institute of Health and Travis Hardcastle from Synthego will present in Room 255 on Friday, June 16, 2023, at 11:30 am ET.